Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
133,900 Preferred Stock of BridgeBio Pharma, Inc. are subject to a Lock-Up Agreement Ending on 13-SEP-2026.
9+ hour, 45+ min ago (144+ words) marketscreener.com 133,900 Preferred Stock of BridgeBio Pharma, Inc are subject to a Lock-Up Agreement Ending on 13-SEP-2026 These Preferred Stock will be under lockup for 31 days starting from 13-AUG-2026 to 13-SEP-2026.Details:The selling stockholder has agreed with the underwriters,…...
Abu Dhabi Government Eyes Collaboration With Germany's Bayer
39+ min ago (42+ words) Published on 09/13/2026 at 05:42 am EDT Donald Trump prepares new agreements to reduce drug prices August 31, 2026 at 02:13 pm EDT Bayer: Q2 surpassed expectations; now focus on deleveraging and operational delivery Can Bayer Still Recover?...
Phase III ARTEMIS-008 trial shows risvutatug rezetecan significantly improves overall survival in relapsed small-cell lung cancer
7+ hour, 18+ min ago (137+ words) B7-H3-directed antibody-drug conjugate reduced the risk of death by 54% compared with topotecan and improved progression-free survival and response rates At the June 6, 2026 data cutoff, after a median follow-up of 12.2 months, median overall survival was 18.5 months with Ris-Rez compared with 10.3 months…...
Novartis Major Shareholder Calls for Board Shake-Up After Back-to-Back Drug Trial Setbacks
5+ hour, 21+ min ago (463+ words) Zurich: A major shareholder in Novartis has called for a shake-up of the Swiss drugmaker's board to improve corporate governance after its shares suffered a record fall this week following back-to-back trial setbacks. David Samra, managing director at Artisan Partners…...
Tam-Peli meets primary endpoint for relapsed small-cell lung cancer in phase III trial
3+ hour, 47+ min ago (401+ words) The Clinical Trial Vanguard Tam-Peli meets primary endpoint for relapsed small-cell lung cancer in phase III trial Topotecan has been the default second-line chemotherapy for relapsed small-cell lung cancer for decades, and its survival benefit in that setting is modest…...
Phio Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Lohud | The Journal News
14+ hour, 36+ min ago (118+ words) Management to Meet with Investors and Highlight Progress and Future Development Plans for PH-762 Robert Bitterman, President and Chief Executive Officer, and Lisa Carson, Chief Financial Officer, will be available for meetings with investors throughout the conference. At the conference,…...
Germantown???s Seraxis Announces Merger to Form Diabetes-Focused Biotech Company
12+ hour, 21+ min ago (339+ words) Announced September 8, the merger is expected to close in November 2026, subject to shareholder approval. The combined company will be headquartered in Germantown, with integrated research laboratories and manufacturing capabilities. Seraxis, a private biotechnology company launched in 2013, is located at 20400 Century…...
AstraZeneca's oral SERD stumbles in Phase III first-line breast cancer trial
4+ hour, 29+ min ago (12+ words) firstwordpharma.com...
Gelatin Hydrogel Salbutamol Study Retracted Over Overlapping Microscopy
3+ hour, 38+ min ago (682+ words) A study that promised a new way to deliver the asthma drug salbutamol sulphate through gelatin-based swellable hydrogels has been struck from the scientific record....
Farm Waste Turned Water Filters Could Scrub Aspirin Pollution From
4+ hour, 10+ min ago (75+ words) Every year, humanity swallows roughly 35,000 metric tons of aspirin, and much of it does not simply vanish after doing its job. A sweeping new review published in Advances in Industrial and Engineering Chemistry argues that one of the world’s oldest…...